oa Transcatheter aortic valve implantation

References

1. Di Mario C, Beatt K and Serruys PW  et al.  Aortic balloon valvuloplasty: a treatment sine cura?. British Heart Journal. 1988;
   [Google Scholar]
2. Daly MJ, Monaghan M, Hamilton A, Lockhart C, Kodoth V, Pillai S, Manoharan G and Spence MS.  Short-term efficacy of palliative balloon aortic valvuloplasty in selected patients with high operative risk. Journal of Invasive Cardiol. 2012 Feb; 24::2, 58–62.
   [Google Scholar]
3. Saia F, Marrozzini C and Moretti C  et al.  The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. EuroIntervention. 2011; 7::723–729.
   [Google Scholar]
4. Cribier A, Eltchaninoff H and Bash A  et al.  Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002; 106::3006–3008.
   [Google Scholar]
5. Leon MB, Smith CR and Mack M  et al.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Eng J Med. 2010; 363::1597–1607.
   [Google Scholar]
6. Smith CR, Leon MB and Mack MJ  et al.  Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011; 364::2187–2198.
   [Google Scholar]
7. Szeto WY, Augoustides JG, Desai ND, Moeller P, McGarvey ML, Walsh E, Bannan A, Herrmann HC and Bavaria JE.  Cerebral embolic exposure during transfemoral and transapical transcatheter aortic valve replacement. J Card Surg. 2011 Jul; 26::4, 348–354.
   [Google Scholar]
8. Gurvitch R, Cheung A and Ye J  et al.  Transcatheter valve-in-valve implantation for failed surgical bioprosthetic valves. J Am Coll Cardiol. 2011; 58::2196–2209.
   [Google Scholar]
9. Piazza N, Bleiziffer S and Brockmann G  et al.  Transcatheter aortic valve implantation for failing surgical aortic bioprosthetic valve: from concept to clinical application and evaluation. JACC Cardiovasc Interv. 2011; 4::721–742.
   [Google Scholar]
10. Chan PH, Di Mario C and Davies SW  et al.  Transcatheter aortic valve implantation in degenerate failing aortic homograft root replacements. J Am Coll Cardiol. 2011; 58::1729–1730.
    [Google Scholar]
11. Latib A, Ielasi A, Montorfano M, Maisano F, Chieffo A, Cioni M, Mussardo M, Bertoldi L, Shannon J, Sacco F, Covello RD, Figini F, Godino C, Grimaldi A, Spagnolo P, Alfieri O and Colombo A.  Transcatheter valve-in-valve implantation with the Edwards SAPIEN in patients with bioprosthetic heart valve failure: the Milan experience. EuroIntervention. 2012 Jan 26;pii: 20120109-00. [Epub ahead of print] .
    [Google Scholar]
12. Nuis RJ, Van Mieghem NM and Schultz CJ  et al.  Timing and potential mechanisms of new conduction abnormalities during the implantation of the Medtronic CoreValve System in patients with aortic stenosis. Eur Heart J. 2011; 32::2067–2074.
    [Google Scholar]
13. Saia F, Lemos PA, Bordoni B, Cervi E, Boriani G, Ciuca C, Taglieri N, Mariani Jr J, Filho RK and Marzocchi A.  Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: Prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. Catheter Cardiovasc Interv. 2011 Nov 22; [CrossRef] [Epub ahead of print] .
    https://doi.org/10.1002/ccd.23336 [Google Scholar]
14. Koos R, Mahnken AH, Aktug O, Dohmen G, Autschbach R, Marx N and Hoffmann R.  Electrocardiographic and imaging predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. J Heart Valve Dis. 2011 Jan; 20::1, 83–90.
    [Google Scholar]
15. Madershahian N, Scherner M, Liakopoulos O, Rahmanian P, Kuhn E, Hellmich M, Mueller-Ehmsen J and Wahlers T.  Renal impairment and transapical aortic valve implantation: impact of contrast medium dose on kidney function and survival. Eur J Cardiothorac Surg. 2011 Dec 26;[Epub ahead of print] .
    [Google Scholar]
16. Leipsic J, Gurvitch R and Labounty TM  et al.  Multidetector computed tomography in transcatheter aortic valve implantation. JACC Cardiovasc Imaging. 2011; 4::416–429.
    [Google Scholar]
17. Gurvitch R, Webb JG and Yuan R  et al.  Aortic annulus diameter determination by multidetector computed tomography: reproducibility, applicability, and implications for transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2011; 4::1235–1245.
    [Google Scholar]
18. Jabbour Am, Ismail TF and Moat N  et al.  Multimodality imaging in transcatheter aortic valve implantation and post-procedural aortic regurgitation: comparison among cardiovascular magnetic resonance, cardiac computed tomography, and echocardiography. J Am Coll Cardiol. 2011; 58::2165–2173.
    [Google Scholar]
19. Schoenhagen P, Tuzcu EM, Kapadia SR, Desai MY and Svensson LG.  Three-dimensional imaging of the aortic valve and aortic root with computed tomography: new standards in an era of transcatheter valve repair/implantation. Eur Heart J. 2009 Sep; 30::17, 2079–2086.
    [Google Scholar]
20. Bruschi G, De Marco F and Fratto P  et al.  Alternative approaches for trans-catheter self-expanding aortic bioprosthetic valves implantation: single-center experience. Eur J Cardiothorac Surg. 2011; 39::e151-8.
    [Google Scholar]
21. Moat N, Laborde JC and Bruschi G et al. European experience of direct aortic TAVI with a self-expanding prosthesis. Society of Thoracic Surgeons Annual Conference; January 30, 2012; Ft Lauderdale, FL.
22. Bapat V, Khawaja MZ, Attia R, Narayana A, Wilson K, Macgillivray K, Young C, Hancock J, Redwood S and Thomas M  et al.  Transaortic transcatheter aortic valve implantation using edwards sapien valve: A Novel Approach. Catheter Cardiovasc Interv. 2011 Jul 29; [CrossRef] [Epub ahead of print] .
    https://doi.org/10.1002/ccd.23276 [Google Scholar]
23. De Robertis F, Asgar A, Davies S, Delahunty N, Kelleher A, Trimlett R, Mullen M and Moat N.  The left axillary artery–a new approach for transcatheter aortic valve implantation. Eur J Cardiothorac Surg. 2009 Nov; 36::5, 807–812.
    [Google Scholar]
24. Kempfert J, Rastan A and Holzhey D  et al.  Transapical aortic valve implantation: analysis of risk factors and learning experience in 299 patients. Circulation. 2011; 124::S124-9.
    [Google Scholar]
25. Unbehaun A, Pasic M and Dreysse S  et al.  Transapical aortic valve implantation incidence and predictors of paravalvular leakage and transvalvular regurgitation in a series of 358 patients. J Am Coll Cardiol. 2012; 59::211–221.
    [Google Scholar]
26. Ewe SH, Muratori M, Delgado V, Pepi M, Tamborini G, Fusini L, Klautz RJ, Gripari P, Bax JJ, Fusari M, Schalij MJ and Marsan NA.  Hemodynamic and clinical impact of prosthesis-patient mismatch after transcatheter aortic valve implantation. J Am Coll Cardiol. 2011 Oct 25; 58::18, 1910–1908.
    [Google Scholar]
27. Kukucka M, Pasic M, Dreysse S, Mladenow A, Habazettl H, Hetzer R and Unbehaun A.  Patient-prosthesis mismatch after transapical aortic valve implantation: Incidence and impact on survival. J Thorac Cardiovasc Surg. 2012 Feb 11;[Epub ahead of print] .
    [Google Scholar]
28. Haensig M, Lehmkuhl L, Rastan AJ, Kempfert J, Mukherjee C, Gutberlet M, Holzhey DM and Mohr FW.  Aortic valve calcium scoring is a predictor of significant paravalvular aortic insufficiency in transapical-aortic valve implantation. Eur J Cardiothorac Surg. 2012 Jan 12;[Epub ahead of print] .
    [Google Scholar]
29. Van Mieghem NM, Schultz CJ, van der Boon RM, Nuis RJ, Tzikas A, Geleijnse ML, van Domburg RT, Serruys PW and de Jaegere PP.  Incidence, timing, and predictors of valve dislodgment during TAVI with the medtronic corevalve system. Catheter Cardiovasc Interv. 2011 Jul 29; [CrossRef] [Epub ahead of print] .
    https://doi.org/10.1002/ccd.23275 [Google Scholar]
30. Moat NE, Ludman P and de Belder MA  et al.  Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol. 2011; 58::2130–2138.
    [Google Scholar]
31. Paelinck BP, Van Herck PL, Rodrigus I, Claeys MJ, Laborde JC, Parizel PM, Vrints CJ and Bosmans JM.  Comparison of magnetic resonance imaging of aortic valve stenosis and aortic root to multimodality imaging for selection of transcatheter aortic valve implantation candidates. Am J Cardiol. 2011 Jul 1; 108::1, 92–98.
    [Google Scholar]
32. Abdel-Wahab M, Mostafa AE and Geist V  et al.  Comparison of outcomes in patients having isolated transcatheter aortic valve implantation versus combined with preprocedural percutaneous coronary intervention. Am J Cardiol. 2012; 109::581–586.
    [Google Scholar]
33. Wenaweser P, Pilgrim T and Guerios E  et al.  Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. EuroIntervention. 2011; 7::541–548.
    [Google Scholar]
34. Astarci P, Glineur D, Elkhoury G and Raucent B.  A novel device for endovascular native aortic valve resection for transapical transcatheter aortic valve implantation. Interact Cardiovasc Thorac Surg. 2012 Jan 9;[Epub ahead of print] .
    [Google Scholar]
35. Bagur R, Rodés-Cabau J and Doyle D  et al.  Usefulness of TEE as the primary imaging technique to guide transcatheter transapical aortic valve implantation. JACC Cardiovasc Imaging. 2011; 4::115–124.
    [Google Scholar]
36. Gurvitch R, Tay EL, Wijesinghe N, Ye J, Nietlispach F, Wood DA, Lichtenstein S, Cheung A and Webb JG.  Transcatheter aortic valve implantation: lessons from the learning curve of the first 270 high-risk patients. Catheter Cardiovasc Interv. 2011 Dec 1; 78::7, 977–984.
    [Google Scholar]
37. Lange R, Bleiziffer S and Mazzitelli D  et al.  Improvements in transcatheter aortic valve implantation outcomes in lower surgical risk patients a glimpse into the future. J Am Coll Cardiol. 2012; 59::280–287.
    [Google Scholar]
38. Dimitrow PP, Jawien M and Rajtar-Salwa R.  Pharmacotherapy of aortic stenosis - success or failure?. Curr Pharm Biotechnol. 2012 Jan 20;[Epub ahead of print] .
    [Google Scholar]
39. Teo KK, Corsi DJ, Tam JW, Dumesnil JG and Chan KL.  Lipid lowering on progression of mild to moderate aortic stenosis: meta-analysis of the randomized placebo-controlled clinical trials on 2344 patients. Can J Cardiol. 2011 Nov; 27::6, 800–808. Epub 2011 Jul 13 .
    [Google Scholar]
40. Athauda-Arachchi P and Lang C.  Metabolic Antianginal Agent Ranolazine Offers Good Symptom Relief in a Patient with Inoperable Severe Aortic Stenosis. Cardiovasc Ther. 2011 May 25;
    [Google Scholar]